Dissertações em Neurociências e Biologia Celular (Mestrado) - PPGNBC/ICB
URI Permanente para esta coleçãohttps://repositorio.ufpa.br/handle/2011/2375
O Mestrado Acadêmico pertence ao Programa de Pós-Graduação em Neurociências e Biologia Celular (PPGNBC) do Instituto de Ciências Biológicas (ICB) da Universidade Federal do Pará (UFPA).
Navegar
Navegando Dissertações em Neurociências e Biologia Celular (Mestrado) - PPGNBC/ICB por Linha de Pesquisa "PATOLOGIA DE CÉLULAS E MOLÉCULAS"
Agora exibindo 1 - 4 de 4
- Resultados por página
- Opções de Ordenação
Item Acesso aberto (Open Access) Análise da ação cicatrizante dos extratos da folha, pecíolo e caule da Montrichardia linifera (Arruda) Schott in vitro(Universidade Federal do Pará, 2020-02-17) BASTOS, Aline Costa; YAMADA, Elizabeth Sumi; http://lattes.cnpq.br/7240314827308306; BASTOS, Gilmara de Nazareth Tavares; http://lattes.cnpq.br/2487879058181806Chronic injuries affect a large portion of society, treatment for these patients has high financial costs and a result that is not satisfactory. Thus, the objective of this work was to investigate whether ethanolic extracts from the stem, petiole and leaf of Montrichardia linifera (Arruda) Schott have healing activity in vitro. For that, the identification of substance classes of the extracts was carried out by HPTLC, the analyzes of: cytotoxicity, in vitro healing, hematoxylin and eosin morphology and immunomarking for BrdU was also performed. This demonstrated the antioxidant activity and the presence of terpenes in the three extracts, and the presence of flavonoids and phenols in the leaf extract. A serial curve was performed with concentrations of 100 to 0.19 μg / ml of the extracts of the stem, petiole and leaf, in times of 24, 48 and 72h, and it did'n present cytotoxicity. From the cytotoxicity test, the concentrations of 0.78, 0.39; 0.19 μg/ml of the three extracts were chosen for the next tests. Thus, the control group in 6, 12 and 24 hours showed a lesion area of 82.08 ± 12.13, 56.14 ± 15.75, 34.34 ± 10.12%, respectively; while the extract of the stem showed lesion area, in the time of 6h, of 66.108 ± 23.85, 66.10 ± 13.13, 64.81 ± 20.42%, respectively; in 12h, 38.86 ± 20.66, 40.45 ± 14.64, 32.29 ± 16.62, respectively; in 24h, 13.48 ± 11.20, 10.67 ± 7.94, 10.15 ± 7.35%, respectively. The petiole extract showed a lesion area, in 6h, 74.02 ± 15.16%, 80.32 ± 22.50%, 75.56 ± 20.09%, respectively; at 12h, 38.86 ± 20.66, 46.79 ± 12.46, 40.98 ± 5.45%, respectively; in 24h, 13.48 ± 11.21, 27.33 ± 13.86, 12.40 ± 7.72%, respectively. The leaf extract, on the other hand, showed a lesion area, in the time of 6h, 73.08 ± 21.35, 72.91 ± 18.19, 67.84 ± 17.89%, respectively; in 12h, 48.76 ± 21.17, 48.02 ± 17.30, 44.54 ± 18.70%, respectively, in 24h, 24.59 ± 14.58, 26.07 ± 16 , 73, 23.75 ± 15.76%, respectively. There was no significant morphological change in hematoxylin and eosin staining. In the quantification of positive BrdU cells, the control group showed an average of 19.778 ± 3.80, while the groups treated with the extracts at concentrations of 0.78, 0.39, 0.19 μg/ml, for the extract of stem, demonstrated mean of 20.222 ± 1.855, 37.889 ± 7.407, 29.778 ± 4.521 positive BrdU cells, respectively, for petiole extract, mean of 20.222 ± 2.587, 20.444 ± 5.077, 24.889 ± 3.551 positive BrdU cells, respectively; for leaf extract, mean of 20,556 ± 3,504, 23,778 ± 5,974, 22,889 ± 3,1798 positive BrdU cells, respectively. Therefore, Montrichardia linifera stem and petiole extract, in small concentrations, demonstrated wound healing activity in vitro.Item Acesso aberto (Open Access) Avaliação in vitro do potencial genotóxico e citotóxico do extrato do açaí (Euterpe oleracea) clarificado sobre a linhagem celular AGP01 (câncer gástrico)(Universidade Federal do Pará, 2024-01) SANTOS, Thiago Souza; BAHIA, Marcelo de Oliveira; http://lattes.cnpq.br/3219037174956649; BURBANO, Rommel Mario Rodríguez; http://lattes.cnpq.br/4362051219348099; https://orcid.org/0000-0002-4872-234XAçaí (Euterpe oleracea MART) is a fruit of great importance for the Amazon region in nutritional, cultural and socioeconomic terms. In recent years, açaí has been the subject of several studies due to its beneficial properties for health, including effects against tumor cells. Therefore, the present work aimed to evaluate in vitro the genotoxic and cytotoxic effects of the clarified extract of açaí juice in a human metastatic gastric cancer cell line (AGP01 cells). For comparison purposes, a non-transformed cell line of African green monkey renal epithelial cells (VERO cells) was used. The viability assay by resazurin reduction, the comet assay, the determination of cell death by differential fluorescent dyes and the wound healing migration assay were performed. A reduction in viability was observed only in the AGP01 line within 72h. There was no genotoxic damage or cell death (through apoptosis or necrosis) in any of the cell lines. However, açaí extract induced motility reduction in both cell lines. The reduction in cell viability and the induction of the anti-migratory effect in the AGP01 cell line opens perspectives for exploring the potential of Euterpe oleracea as an adjuvant in the treatment of gastric cancer.Item Acesso aberto (Open Access) Impacto da busca ativa especializada no diagnóstico da hanseníase: avaliação longitudinal e comparativa de aspectos clínicos e laboratoriais em áreas endêmicas no Pará e no Maranhão(Universidade Federal do Pará, 2024-08) COSTA, Izabelle Laissa Viana; COSTA, Patrícia Fagundes; http://lattes.cnpq.br/6487407290759330; SALGADO, Claudio Guedes; http://lattes.cnpq.br/2310734509396125Leprosy is a disease that represents a significant public health problem in various parts of the world, including Brazil. To improve epidemiological data, active case finding activities and longitudinal research represent a transformative approach to disease control. In this context, the present study aimed to evaluate and compare the clinical and laboratory aspects of patients with leprosy, their contacts, and schoolchildren over a one-year period in endemic areas in Pará and Maranhão. To achieve this, a longitudinal study was conducted, characterized by active case finding activities in Imperatriz-MA, São Luís-MA, and Marituba-PA, where registered leprosy cases in the Notifiable Diseases Information System (SINAN), their contacts, and school-aged children were evaluated. Participants underwent neurodermatological evaluation and blood collection for the titration of IgM anti-PGL-I antibodies, as well as intradermal scraping of the earlobes and elbows for bacilloscopy and qPCR. After one year, in 2023, participants from the municipalities of Imperatriz and São Luís were re-evaluated, and new participants were included. Among 522 individuals included in this study, 135/522 (25.9%) were clinically and/or laboratorially re-evaluated in 2023, and 387/522 (74.1%) were evaluated exclusively in 2022 or 2023. In 2022, new cases were identified among 66/221 (29.9%) contacts and 23/195 (11.8%) schoolchildren. Additionally, 9/34 (26.5%) relapses and 2/34 (5.9%) patients with therapeutic insufficiency or failure were diagnosed among index cases. In 2023, new cases were observed among 70/126 (55.5%) contacts and 10/29 (34.4%) schoolchildren. Furthermore, 7/12 (58.3%) relapses and 1/12 (8.3%) patients with therapeutic insufficiency or failure were diagnosed among index cases. In the neurodermatological evaluation, among schoolchildren and contacts who were re-evaluated, individuals with an altered superficial fibular nerve were found to be 4.3 times more likely to be in the disease case group (p < 0.05; 95% CI = 1.58- 12.74; OR = 4.32). The bacilloscopy test identified the etiological agent in 7/222 evaluated individuals (3.1%), with 4/7 (57.1%) being among individuals with a prior diagnosis of leprosy. Regarding the serological analysis of re-evaluated individuals, seropositivity was observed in 26/106 (24.5%) individuals in 2022, and 7/106 (6.6%) in 2023, a statistically significant decrease (p < 0.05). A high positivity rate for the qPCR technique was observed, including 9/10 (90%) relapses, 55/88 (62.8%) new cases, and 43/151 (48.3%) contacts. These data highlight a concerning scenario characterized by a high number of hidden leprosy cases in the analyzed regions, and a significant increase in diagnosis rates after one year of follow-up in the communities, underscoring the importance of longitudinal research and the implementation of different diagnostic and monitoring techniques for a better understanding of leprosy and its outcomes in endemic areas.Item Acesso aberto (Open Access) Pesquisa de hanseníase em doadores de sangue(Universidade Federal do Pará, 2024-11) JORGE, Erika Vanessa Oliveira; PALMEIRA, Mauricio Koury; http://lattes.cnpq.br/2785104508455046; SALGADO, Claudio Guedes; http://lattes.cnpq.br/2310734509396125Hansen’s disease (HD) is an infectious disease with active transmission in endemic areas such as Brazil, which accounted for over 90% of the new HD in the Americas in 2021, and the second highest in the global scale. Clinically is characterized by the appearance of nerve or skin lesions with altered sensitivity, that in advanced cases, can cause deformities and physical disabilities. Its transmission occurs mainly through Mycobacterium leprae, through respiratory droplets of sick people, and has a prolonged incubation period. The diagnosis of leprosy is clinical, with multidrug treatment PQT (polychemotherapy) being crucial to avoid the chain of disease transmission. Suspected cases should be attended by a qualified professional in basic health units or active case finding campaigns. Although leprosy patient is considered definitively unfit for blood donation process, according to Consolidation regulation nº 5, of October 3, 2017, leprosy investigation occurs only through a clinical interview, without laboratory evaluation. At Hemocenter from Pará, 500 donors were selected for the study and blood was collected for serological investigation of anti-PGL-I antibodies. Of the selected donors, 4% (20/500) had positive serological results greater than or equal to 0,750 optical density among only eight agreed to be clinically examined and underwent other laboratory tests: bacilloscopy and qPCR. Among donors with clinical evaluation, more than half were diagnosed with leprosy, 62.5% (5/8), with the following cases: one individual with the primarily neural clinical form, three with borderline-tuberculoid, one lepromatous. of peripheral blood, the presence of the bacillus in two individuals was confirmed, suggesting a possible route of transmission of the disease. We emphasize that the prevalence of subclinical leprosy infection due to its etiological agent among the study population is very high, but compatible with the hidden prevalence already recorded in the state of Pará.